Stay updated on Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Sign up to get notified when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the prior v3.5.3 tag. This indicates a minor page version update rather than any change to the study data.
    Difference
    0.0%
    Check dated 2026-05-14T23:09:09.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page shows a new revision label. It updates from Revision: v3.5.2 to Revision: v3.5.3, signaling a software release rather than substantive changes to the study data or content.
    Difference
    0.0%
    Check dated 2026-04-30T14:26:40.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No user-facing content or layout changes are evident.
    Difference
    0.0%
    Check dated 2026-04-16T10:14:22.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T16:45:37.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A backend version update shows revision v3.4.3 replacing v3.4.2. No visible changes to study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-03-11T14:43:46.000Z thumbnail image
  9. Check
    111 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown on the page. Notices about government funding lapse and an older Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:51:28.000Z thumbnail image

Stay in the know with updates to Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.